182 results
Page 5 of 10
8-K
EX-99.1
8qri8ip66f1ny5nh
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
424B5
usmwud4
18 Dec 20
Prospectus supplement for primary offering
1:26pm
424B5
ypf 7qhogqi1ptw
2 Oct 20
Prospectus supplement for primary offering
4:24pm
8-K
ghuu1s a3jzzj
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.1
xhdc5
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-99.1
2zhxjbi
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
424B5
go84mvdyfcriuf
4 Aug 20
Prospectus supplement for primary offering
6:16am
8-K
wplu vwqq7j5n3
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
8-K
EX-10.1
6hz 93eebdpu
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
8-K
EX-99.1
axurk
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
424B5
ml9h13zihi7
10 Jul 20
Prospectus supplement for primary offering
2:35pm
8-K
qys9q3 e8ol4zez
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-10.1
xxnus17jp2v
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-99.1
9e43enyjhrri8cjj4toc
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am